rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John Donofrio Jr.

Director

Company insider

Files Form 4 as: Director, Aytu BioPharma.

Every Form 4 they filed

In numbers

Trades disclosed
14
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
12 Jul 2016
Last trade
28 Jul 2026
Last filed
30 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
AYTU Aytu BioPharmaDirector · Biotechnology · last 28 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 Jul 2026filed 30 Jul 2026AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
28 Jul 2026filed 30 Jul 2026AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
3 Oct 2025filed 7 Oct 2025AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
6 Nov 2024filed 8 Nov 2024AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
11 Aug 2023filed 15 Aug 2023AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
21 Dec 2022filed 23 Dec 2022AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code D—187,804 at $0.00filing
16 Apr 2021filed 16 Apr 2021AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—187,804 at $0.00filing
8 Jun 2020filed 12 Jun 2020AYTU Aytu BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
24 Oct 2018filed 26 Oct 2018AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—150,000filing
7 Nov 2017filed 9 Nov 2017AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—50,000filing
16 Mar 2017filed 17 Mar 2017AYTU Aytu BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code D—15,000 at $0.00filing
16 Mar 2017filed 17 Mar 2017AYTU Aytu BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
12 Jul 2016filed 18 Jul 2016AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—65,000 at $0.00filing
12 Jul 2016filed 18 Jul 2016AYTU Aytu BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Vivian H. LiuDirector · Director at Aytu Biopharma, filing Form 4 there in the last year
Joshua R. DisbrowChief Executive Officer · Chief Executive Officer at Aytu Biopharma, filing Form 4 there in the last year
Carl DockeryDirector · Director at Aytu Biopharma, filing Form 4 there in the last year
Jarrett DisbrowChief Business Officer · Chief Business Officer at Aytu Biopharma, filing Form 4 there in the last year
Ryan J. SelhornChief Financial Officer · Chief Financial Officer at Aytu Biopharma, filing Form 4 there in the last year